SLRN - ACELYRIN Quarterly EPS earnings growth

Acelyrin, Inc. (SLRN) - corporate logo

Acelyrin, Inc. (SLRN) utilizes laboratory automation to accelerate the analysis of cellular responses. Innovative anti-inflammatory tools and patent protection establish the foundation for future cash flow growth. The quarterly earnings per share history demonstrates current dynamics, where -53.50 reflects the metric's baseline while the biotech's reputation stabilizes amid moderate investor confidence.

acelyrin.com (SLRN) Year-over-year earnings per one share growth for the last 12 months: for the period 02/21/2024 - 05/31/2025

Analytical breakdowns and data insights for company ACELYRIN Inc. (SLRN)

- share price and expert price forecast:
Stock Price ACELYRIN|SLRN - Fair Value Consensus
- market capitalization statistics:
Market Capitalization ACELYRIN, Inc.|SLRN - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share ACELYRIN|SLRN - Accounting Value of Company|Market Capitalization to Book Value Ratio acelyrin.com|SLRN - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Acelyrin, Inc.|SLRN - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Acelyrin, Inc.|SLRN - Company Cumulative Debt|Debt to Book Capitalization Ratio ACELYRIN, Inc.|SLRN - Company Long-Term Debt|Company Current Liabilities ACELYRIN|Quick Liquidity acelyrin.com
- earnings and market multiples details:
SLRN - Final Profit|Projected Future Earnings Acelyrin, Inc.|SLRN - Business Payback Period|Future Price to Earnings ACELYRIN, Inc.|SLRN - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio ACELYRIN, Inc.|SLRN - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ACELYRIN|SLRN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months acelyrin.com|SLRN - Earnings per share growth this year|Earnings growth forecast for next year Acelyrin, Inc.
- sales revenue and business income indicators:
SLRN - Company Sales|Company Future Sales Volume ACELYRIN|SLRN - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio ACELYRIN, Inc.
Comprehensive company analysis:Acelyrin, Inc.
Flagship merchandise of ACELYRIN Inc.

Acelyrin, Inc. (SLRN) is accelerating the development of immunological drugs by implementing laboratory robotics, thereby minimizing human error in the analysis of cellular reactions. The efficiency of this automation is reflected in the quarterly earnings per share (EPS) trend, which measures the growth rate of net income, allowing for an assessment of capital resilience against inflation and the mitigation of risks when extrapolating peak profit values.

Direct competitors

HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PRGO (Perrigo)|Quarterly EPS earnings growth Alvotech S.A. ALVO|Liquidia Technologies - Quarterly EPS earnings growth|Galapagos Corp (GLPG) - Year-over-year net earnings per share growth for the last 12 months|ANIP: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months mannkindcorp.com (MNKD)|Year-over-year earnings per share growth for the last twelve months Amphastar Pharmaceuticals, Inc.|Year-over-year earnings per share growth for the last twelve months PCRX|Year-over-year net earnings per share growth for the last 12 months SPRY (ARS Pharma)|TBPH - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Aquestive Therapeutics AQST|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Tonix Pharma TNXP|sxtchina.com (SXTC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EPRX|Year-over-year net earnings per share growth for the last 12 months BHST|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORMP|Year-over-year net earnings per share change for the last twelve months enterabio.com|Year-over-year earnings per share growth for the last twelve months MindWalk HYFT|ABVC: Year-over-year earnings per share growth for the last 12 months|Cumberland Pharmaceuticals - Quarterly EPS earnings growth|quantumbiopharma.com (QNTM) - Year-over-year net earnings per share growth for the last 12 months|FGEN (FibroGen) - Year-over-year net earnings per share growth for the last 12 months|TELO - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Rani Therapeutics Holdings|Synergy CHC Corporation (SNYR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Rallybio Corporation (RLYB)|Year-over-year earnings per share growth for the last twelve months LEXX (lexariabioscience.com)|Year-over-year earnings per share growth for the last twelve months Pulmatrix PULM|Year-over-year earnings per one share growth for the last 12 months PTHL|APM - Year-over-year earnings per share growth for the last twelve months|LYRA (Lyra Therapeutics Inc) - Year-over-year earnings per share growth for the last 12 months|Impact BioMedical (IBO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months TNFA (TNF Pharmaceuticals, Inc.)|YCBD (cbdMD Inc.) - Quarterly EPS earnings growth|PRFX: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CYTO|Quarterly EPS earnings growth Lipella Pharma (LIPO)|Year-over-year earnings per share growth for the last twelve months OptiNose, Inc. OPTN|Year-over-year earnings per one share growth for the last 12 months PIRS|PROC - Year-over-year earnings per share growth for the last twelve months|Petros Pharmaceuticals Inc (PTPI) - Year-over-year net earnings per share growth for the last 12 months|QLI: Quarterly EPS earnings growth|TFF Pharmaceuticals, Inc (TFFP) - Quarterly EPS earnings growth